# Upexi, Inc.: financial statements, quarterly

UPXI · Nasdaq · CIK 1775194 · [Financials](/sectors/financials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/upxi.md) · [Financials](/companies/upxi/financials.md) · [Filings](/companies/upxi/filings.md) · [Insiders](/companies/upxi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/upxi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [8.3](/filings/0001477932-24-008219.md) | [7.5](/filings/0001477932-25-001048.md) | [5.2](/filings/0001477932-25-003866.md) | [5.0 d](/filings/0001477932-25-006996.md) | [4.4](/filings/0001477932-25-008025.md) | [4.0](/filings/0001477932-26-000736.md) | [0.0](/filings/0001477932-26-003001.md) | [1.0 d](/filings/0001477932-26-005668.md) | [9.2](/filings/0001477932-25-008025.md) | [8.1](/filings/0001477932-26-000736.md) | [3.5](/filings/0001477932-26-003001.md) | [2.7 d](/filings/0001477932-26-005668.md) |
| Cost of revenue | $m | [2.8](/filings/0001477932-24-008219.md) | [2.9](/filings/0001477932-25-001048.md) | [4.0](/filings/0001477932-25-003866.md) | [3.5 d](/filings/0001477932-25-006996.md) | [1.4](/filings/0001477932-25-008025.md) | [1.0](/filings/0001477932-26-000736.md) | [1.6](/filings/0001477932-26-003001.md) | [0.9 d](/filings/0001477932-26-005668.md) | [1.0](/filings/0001477932-25-008025.md) | [1.3](/filings/0001477932-26-000736.md) | [0.2](/filings/0001477932-26-003001.md) | [0.1 d](/filings/0001477932-26-005668.md) |
| Gross profit | $m | [5.4](/filings/0001477932-24-008219.md) | [4.6](/filings/0001477932-25-001048.md) | [1.3](/filings/0001477932-25-003866.md) | [1.6 d](/filings/0001477932-25-006996.md) | [2.9](/filings/0001477932-25-008025.md) | [3.0](/filings/0001477932-26-000736.md) | [1.6](/filings/0001477932-26-003001.md) | [3.4 d](/filings/0001477932-26-005668.md) | [8.3](/filings/0001477932-25-008025.md) | [6.7](/filings/0001477932-26-000736.md) | [4.4](/filings/0001477932-26-003001.md) | [3.0 d](/filings/0001477932-26-005668.md) |
| Operating income | $m | [(1.5)](/filings/0001477932-24-008219.md) | [(2.6)](/filings/0001477932-25-001048.md) | [(5.0)](/filings/0001477932-25-003866.md) | [(13.4) d](/filings/0001477932-25-006996.md) | [(1.3)](/filings/0001477932-25-008025.md) | [(1.1)](/filings/0001477932-26-000736.md) | [(3.6)](/filings/0001477932-26-003001.md) | [(6.5) d](/filings/0001477932-26-005668.md) | [69.2](/filings/0001477932-25-008025.md) | [(175)](/filings/0001477932-26-000736.md) | [(107)](/filings/0001477932-26-003001.md) | [(27.9) d](/filings/0001477932-26-005668.md) |
| Interest expense | $m | [0.8](/filings/0001477932-24-008219.md) | not reported | not reported | not reported | [0.0](/filings/0001477932-25-008025.md) | [0.1](/filings/0001477932-26-000736.md) | [0.0](/filings/0001477932-26-003001.md) | [0.0 d](/filings/0001477932-26-005668.md) | [0.0](/filings/0001477932-25-008025.md) | [0.0](/filings/0001477932-26-000736.md) | [0.0](/filings/0001477932-26-003001.md) | [0.0 d](/filings/0001477932-26-005668.md) |
| Income tax | $m | [0.5](/filings/0001477932-24-008219.md) | [0.7](/filings/0001477932-25-001048.md) | [1.5](/filings/0001477932-25-003866.md) | [(3.0) d](/filings/0001477932-25-006996.md) | [0.0](/filings/0001477932-25-008025.md) | [0.0](/filings/0001477932-26-000736.md) | [0.0](/filings/0001477932-26-003001.md) | [0.0 d](/filings/0001477932-26-005668.md) | [0.0](/filings/0001477932-25-008025.md) | [0.0](/filings/0001477932-26-000736.md) | [0.0](/filings/0001477932-26-003001.md) | [0.0 d](/filings/0001477932-26-005668.md) |
| Net income | $m | [(1.4)](/filings/0001477932-25-003866.md) | [(2.4)](/filings/0001477932-25-003866.md) | [(4.1)](/filings/0001477932-25-003866.md) | [(15.7) d](/filings/0001477932-25-006996.md) | [(1.6)](/filings/0001477932-26-003001.md) | [(1.3)](/filings/0001477932-26-003001.md) | [(3.8)](/filings/0001477932-26-003001.md) | [(6.9) d](/filings/0001477932-26-005668.md) | [66.7](/filings/0001477932-26-003001.md) | [(179)](/filings/0001477932-26-003001.md) | [(109)](/filings/0001477932-26-003001.md) | [(24.5) d](/filings/0001477932-26-005668.md) |
| Diluted EPS | $ per share | [(1.34)](/filings/0001477932-24-008219.md) | [(2.00)](/filings/0001477932-25-001048.md) | [(4.03)](/filings/0001477932-25-003866.md) | not reported | [1.55](/filings/0001477932-25-008025.md) | [(1.24)](/filings/0001477932-25-001048.md) | [(2.87)](/filings/0001477932-26-003001.md) | not reported | [0.76](/filings/0001477932-25-008025.md) | not reported | [(1.67)](/filings/0001477932-26-003001.md) | not reported |
| Basic EPS | $ per share | [(1.34)](/filings/0001477932-24-008219.md) | [(2.00)](/filings/0001477932-25-001048.md) | [(4.03)](/filings/0001477932-25-003866.md) | not reported | [(1.55)](/filings/0001477932-25-008025.md) | [(1.24)](/filings/0001477932-26-000736.md) | [(2.87)](/filings/0001477932-26-003001.md) | not reported | [1.21](/filings/0001477932-25-008025.md) | [(2.94)](/filings/0001477932-26-000736.md) | [(1.67)](/filings/0001477932-26-003001.md) | not reported |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.4](/filings/0001477932-23-008695.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [24.9](/filings/0001477932-23-008695.md) | [22.6](/filings/0001477932-24-000734.md) | [16.8](/filings/0001477932-24-004117.md) | [11.4](/filings/0001477932-25-006996.md) | [6.8](/filings/0001477932-24-008219.md) | [6.1](/filings/0001477932-25-001048.md) | [4.0](/filings/0001477932-25-003866.md) | [56.8](/filings/0001477932-26-005668.md) | [220](/filings/0001477932-25-008025.md) | [171](/filings/0001477932-26-000736.md) | [122](/filings/0001477932-26-003001.md) | [117](/filings/0001477932-26-005668.md) |
| Total assets | $m | [65.2](/filings/0001477932-23-008695.md) | [62.2](/filings/0001477932-24-000734.md) | [56.5](/filings/0001477932-24-004117.md) | [23.5](/filings/0001477932-25-006996.md) | [18.6](/filings/0001477932-24-008219.md) | [17.5](/filings/0001477932-25-001048.md) | [15.1](/filings/0001477932-25-003866.md) | [124](/filings/0001477932-26-005668.md) | [420](/filings/0001477932-25-008025.md) | [271](/filings/0001477932-26-000736.md) | [200](/filings/0001477932-26-003001.md) | [180](/filings/0001477932-26-005668.md) |
| Current liabilities | $m | [20.0](/filings/0001477932-23-008695.md) | [24.3](/filings/0001477932-24-000734.md) | [24.2](/filings/0001477932-24-004117.md) | [12.7](/filings/0001477932-25-006996.md) | [9.8](/filings/0001477932-24-008219.md) | [10.6](/filings/0001477932-25-001048.md) | [10.8](/filings/0001477932-25-003866.md) | [32.6](/filings/0001477932-26-005668.md) | [64.6](/filings/0001477932-25-008025.md) | [77.9](/filings/0001477932-26-000736.md) | [70.8](/filings/0001477932-26-003001.md) | [71.1](/filings/0001477932-26-005668.md) |
| Long-term debt | $m | [27.4](/filings/0001477932-23-008695.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [19.5](/filings/0001477932-26-005668.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | [0.0](/filings/0001477932-25-006996.md) | not reported | not reported | not reported | [20.0](/filings/0001477932-26-005668.md) | [50.0](/filings/0001477932-25-008025.md) | [62.7](/filings/0001477932-26-000736.md) | [57.3](/filings/0001477932-26-003001.md) | [57.3](/filings/0001477932-26-005668.md) |
| Shareholders' equity | $m | [27.6](/filings/0001477932-25-003866.md) | [25.5](/filings/0001477932-25-003866.md) | [22.1](/filings/0001477932-25-003866.md) | [6.5](/filings/0001477932-26-005668.md) | [5.0](/filings/0001477932-26-003001.md) | [3.8](/filings/0001477932-26-003001.md) | [1.9](/filings/0001477932-26-003001.md) | [90.1](/filings/0001477932-26-005668.md) | [211](/filings/0001477932-26-003001.md) | [48.7](/filings/0001477932-26-003001.md) | [(51.9)](/filings/0001477932-26-003001.md) | [(53.8)](/filings/0001477932-26-005668.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(3,792)](/filings/0001477932-24-008219.md) | [188 d](/filings/0001477932-25-001048.md) | [784 d](/filings/0001477932-25-003866.md) | [2,720 d](/filings/0001477932-25-006996.md) | [(1,975)](/filings/0001477932-25-008025.md) | [(1,384) d](/filings/0001477932-26-000736.md) | [(779) d](/filings/0001477932-26-003001.md) | [(4,286) d](/filings/0001477932-26-005668.md) | [(9,780)](/filings/0001477932-25-008025.md) | [(2,682) d](/filings/0001477932-26-000736.md) | [(4,777) d](/filings/0001477932-26-003001.md) | [(3,718) d](/filings/0001477932-26-005668.md) |
| Capital expenditure | $k | [295](/filings/0001477932-24-008219.md) | [186 d](/filings/0001477932-25-001048.md) | [183 d](/filings/0001477932-25-003866.md) | [270 d](/filings/0001477932-25-006996.md) | [167](/filings/0001477932-25-008025.md) | [0.0 d](/filings/0001477932-26-000736.md) | [30.6 d](/filings/0001477932-26-003001.md) | [190 d](/filings/0001477932-26-005668.md) | [14.8](/filings/0001477932-25-008025.md) | [17.5 d](/filings/0001477932-26-000736.md) | [11.7 d](/filings/0001477932-26-003001.md) | [0.0 d](/filings/0001477932-26-005668.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001477932-26-005668.md) | not reported | not reported | not reported | [0.0 d](/filings/0001477932-26-005668.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [16.7](/filings/0001477932-23-008695.md) | [19.0](/filings/0001477932-23-001046.md) | [18.0](/filings/0001477932-23-003802.md) | [1.0](/filings/0001477932-24-008219.md) | [1.0](/filings/0001477932-25-001048.md) | [1.0](/filings/0001477932-25-003866.md) | [1.0](/filings/0001477932-25-008025.md) | [1.0](/filings/0001477932-26-000736.md) | [1.3](/filings/0001477932-26-003001.md) | [88.5](/filings/0001477932-25-008025.md) | [60.8](/filings/0001477932-26-000736.md) | [65.5](/filings/0001477932-26-003001.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 82,102,474 at 2026-09-15, from the cover of the [10-K filed 2026-09-17](/filings/0001477932-26-005668.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.